What’s the best modality for patient selection for predicting response to PD-1/PD-L1 inhibitors?

Documenti analoghi

• Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
  di: Diggs, Laurence P., et al.
  Pubblicazione: (2017)
• Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
  di: Ming Yi, et al.
  Pubblicazione: (2018-08-01)
• Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
  di: Yi, Ming, et al.
  Pubblicazione: (2018)
• PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer
  di: Hunter, Katerina Ancevski, et al.
  Pubblicazione: (2018)
• PD-1/PD-L1 inhibitors
  di: Sunshine, Joel, et al.
  Pubblicazione: (2015)